60 Day FRN

1496

Federal Register / Vol. 90, No. 5 / Wednesday, January 8, 2025 / Notices

national, state, and local prevention
priorities.
This Revision includes an update to
add three diseases included as part of
Form 57.130—Pathogens of High
Consequence. The original collection
captured the number of patients newly
admitted and currently hospitalized
with certain diseases in acute care
hospitals (e.g.,. Crimean-Congo
Hemorrhagic Fever (CCHF), Dengue,
Ebola, Lassa, Measles, Mpox, MERSCoV, Nipah, and Toxigenic Vibrio
cholerae) broken down by adult patients
and pediatric patients. Three additional
diseases are being added to the data
collection, Influenza A (H5), Marburg,

and Oropouche. Influenza A (H5) has
been on the CDC’s Office of Readiness
and Response website as an active
response. Marburg and Oropouche were
recently added to the website as active
responses due to international
outbreaks. It is crucial for CDC to be
aware of cases of these select infectious
diseases of public health concern to
help ensure that local and state
authorities are equipped to contain and
prevent further spread. Facilities
enrolled in the NHSN Patient Safety
Component will be asked to select the
specific diseases they are reporting on
and then provide the overall number of

patients hospitalized with confirmed
disease along with stratification of
disease in adult and pediatric patients.
The data collection will be collected
electronically via the NHSN application.
This Revision requests OMB approval
for an estimated 111,021 annual burden
hours to be added to Form 57.130—
Pathogens of High Consequence. The
total estimated annual burden hours for
the NHSN package will be increased to
4,508,255. Participation is required for
healthcare facilities that report through
the NHSN platform. There is no cost to
respondents other than their time to
participate.

ESTIMATED ANNUALIZED BURDEN HOURS
Average
burden per
response
(in hours)

Total burden
(in hours)

Form name

Infection Preventionist/Microbiologist

57.130 Pathogens of High Consequence.

3,650

365

5/60

111,021

...........................................................

........................

........................

........................

4,508,255

Total ...........................................

Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Public Health Ethics and
Regulations, Office of Science, Centers for
Disease Control and Prevention.
[FR Doc. 2025–00165 Filed 1–7–25; 8:45 am]
BILLING CODE 4163–18–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day–25–0469; Docket No. CDC–2024–
0105]

Proposed Data Collection Submitted
for Public Comment and
Recommendations
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice with comment period.
AGENCY:

The Centers for Disease
Control and Prevention (CDC), as part of
its continuing effort to reduce public
burden and maximize the utility of
government information, invites the
general public and other federal
agencies the opportunity to comment on
a continuing information collection, as
required by the Paperwork Reduction
Act of 1995. This notice invites
comment on a proposed information
collection project titled National
Program of Cancer Registries Cancer
Surveillance System. This information

SUMMARY:

lotter on DSK11XQN23PROD with NOTICES1

Number of
responses per
respondent

Number of
respondents

Type of respondents

VerDate Sep<11>2014

17:50 Jan 07, 2025

Jkt 265001

collection creates a Cancer Registry that
provides useful data on cancer
incidence, trends, and outcomes.
DATES: CDC must receive written
comments on or before March 10, 2025.
ADDRESSES: You may submit comments,
identified by Docket No. CDC–2024–
0105 by either of the following methods:
• Federal eRulemaking Portal:
www.regulations.gov. Follow the
instructions for submitting comments.
• Mail: Jeffrey M. Zirger, Information
Collection Review Office, Centers for
Disease Control and Prevention, 1600
Clifton Road, NE, MS–D74, Atlanta,
Georgia 30329.
Instructions: All submissions received
must include the agency name and
Docket Number. CDC will post, without
change, all relevant comments to
www.regulations.gov.
Please note: Submit all comments
through the Federal eRulemaking portal
(www.regulations.gov) or by U.S. mail to
the address listed above.
FOR FURTHER INFORMATION CONTACT: To
request more information on the
proposed project or to obtain a copy of
the information collection plan and
instruments, contact Jeffrey M. Zirger,
Information Collection Review Office,
Centers for Disease Control and
Prevention, 1600 Clifton Road, NE, MS–
D74, Atlanta, Georgia 30329; Telephone:
404–639–7570; Email: omb@cdc.gov.
SUPPLEMENTARY INFORMATION: Under the
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3501–3520), federal agencies

PO 00000

Frm 00063

Fmt 4703

Sfmt 4703

must obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct
or sponsor. In addition, the PRA also
requires federal agencies to provide a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each new
proposed collection, each proposed
extension of existing collection of
information, and each reinstatement of
previously approved information
collection before submitting the
collection to the OMB for approval. To
comply with this requirement, we are
publishing this notice of a proposed
data collection as described below.
The OMB is particularly interested in
comments that will help:
1. Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
2. Evaluate the accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and
clarity of the information to be
collected;
4. Minimize the burden of the
collection of information on those who
are to respond, including through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or

E:\FR\FM\08JAN1.SGM

08JAN1

1497

Federal Register / Vol. 90, No. 5 / Wednesday, January 8, 2025 / Notices
other forms of information technology,
e.g., permitting electronic submissions
of responses; and
5. Assess information collection costs.
Proposed Project
National Program of Cancer Registries
Cancer Surveillance System (OMB
Control No. 0920–0469, Exp. 1/31/
2026)—Revision—National Center for
Chronic Disease Prevention and Health
Promotion (NCCDPHP), Centers for
Disease Control and Prevention (CDC).
Background and Brief Description
In 2021, the most recent year for
which complete incidence information
is available, almost 620,000 people died
of cancer and more than 1.8 million
were diagnosed with cancer. It is
estimated that 17 million Americans are
currently alive with a history of cancer.
In the U.S., State/Territory-based central
cancer registries (CCR) are the only
method for systematically collecting and
reporting population-based information
about cancer incidence and outcomes
such as survival. These data are used to
measure the changing incidence and
burden of each cancer; identify
populations at increased or increasing
risk; target preventive measures; and
measure the success or failure of cancer
control efforts in the United States.
In 1992, Congress passed the Cancer
Registries Amendment Act which
established the National Program of
Cancer Registries (NPCR). The NPCR
provides support for State/Territorybased cancer registries that collect,

for state and national cancer control and
prevention. In addition, datasets can be
made available for secondary analysis.
Respondents are NPCR-supported
CCRs in 46 U.S. States, three Territories,
and the District of Columbia. Fifty CCRs
submit data elements specified for the
Standard NPCR CSS Report. Each CCR
is asked to transmit two data files to
CDC per year. The first NPCR CSS
Standard file, submitted in January, is a
preliminary report consisting of one
year of data for the most recent year of
available data. CDC evaluates the
preliminary data for completeness and
quality and provides a report back to the
CCR. The second NPCR CSS Standard
file, submitted in November, contains
cumulative cancer incidence data from
the first diagnosis year for which the
cancer registry collected data with the
assistance of NPCR funds (e.g., 1995)
through 12 months past the close of the
most recent diagnosis year (e.g., 2022).
The cumulative file is used for analysis
and reporting. The burden for each file
transmission is estimated at two hours
per response. Because cancer incidence
data are already collected and
aggregated at the state level, the
additional burden of reporting the
information to CDC is small.
All information is transmitted to CDC
electronically. Participation is required
as a condition of the cooperative
agreement with CDC. CDC requests
OMB approval for an estimated 200
annual burden hours. There are no costs
to respondents except their time.

manage, and analyze data about cancer
cases. The State/Territory-based cancer
registries report information to CDC
through the National Program of Cancer
Registries Cancer Surveillance System
(NPCR CSS), (OMB Control No. 0920–
0469). CDC plans to request OMB
approval to continue collecting this
information for three years. Data
definitions will be updated to reflect
changes in national standards for cancer
diagnosis and coding. No changes to the
total estimated annualized burden hours
or number of respondents are
anticipated.
The NPCR CSS allows CDC to collect,
aggregate, evaluate, and disseminate
cancer incidence data at the national
level. The NPCR CSS is the primary
source of information for the United
States Cancer Statistics (USCS), which
CDC has published annually since 2002.
The latest USCS report published in
2024 provided cancer statistics for 98%
of the U.S. population from all cancer
registries in the United States. Prior to
the publication of USCS, cancer
incidence data at the national level were
available for only 14% of the population
of the United States. The NPCR CSS also
allows CDC to monitor cancer trends
over time, describe geographic variation
in cancer incidence throughout the
country, and provide incidence data on
populations by race, ethnicity, and other
demographic and tumor characteristics
and data on rare cancers. These
activities and analyses further support
CDC’s planning and evaluation efforts

ESTIMATED ANNUALIZED BURDEN HOURS
Number of
responses per
respondent

Number of
respondents

Total burden
(in hours)

Form name

Central Cancer Registries in States,
Territories, and the District of Columbia.

Standard NPCR CSS Report ...........

50

2

2

200

Total ...........................................

...........................................................

........................

........................

........................

200

Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Public Health Ethics and
Regulations, Office of Science, Centers for
Disease Control and Prevention.

ACTION:

Centers for Disease Control and
Prevention

SUMMARY:

[Docket No. CDC–2025–0002]

BILLING CODE 4163–18–P

Establishing a Road Map for
Accelerated Diagnosis and Treatment
of HCV Infection in the United States
Centers for Disease Control and
Prevention, Health, and Human Services
(HHS).

AGENCY:

VerDate Sep<11>2014

17:50 Jan 07, 2025

Jkt 265001

Notice of public meeting and
request for comment.

DEPARTMENT OF HEALTH AND
HUMAN SERVICES

[FR Doc. 2025–00163 Filed 1–7–25; 8:45 am]

lotter on DSK11XQN23PROD with NOTICES1

Average
burden per
response
(in hours)

Type of respondents

PO 00000

Frm 00064

Fmt 4703

Sfmt 4703

The Centers for Disease
Control and Prevention (CDC)
announces a two-day convening hosted
and facilitated by the Association of
Public Health Laboratories (APHL) to
discuss hepatitis C diagnostics. Leaders
from public health, laboratory, medical,
academic, and industry sectors will
have the opportunity to provide
individual input, without building a
consensus, on accelerating the diagnosis
of current hepatitis C virus (HCV)

E:\FR\FM\08JAN1.SGM

08JAN1